| PUFA | Polyunsaturated fatty acid | COX | Cyclooxygenase |
| LOX | Lipoxygenase | CYP | Cytochrome P450 |
| LA | Linoleic acid | ALA | Alpha-linolenic acid |
| AA | Arachidonic acid | DGLA | Dihomo-gamma-linolenic acid |
| EPA | Eicosapentaenoic acid | DHA | Docosahexaenoic acid |
| PG | Prostaglandin | TX | Thromboxane |
| LT | Leukotriene | NAFLD | Non-alcoholic fatty liver disease |
| NAFL | Non-alcoholic fatty liver | NASH | Non-alcoholic steatohepatosis |
| 5-oxo-ETE | 5-Oxo-eicosatetraenoic acid | HETE | Hydroxyeicosatetraenoic acid |
| HEPE | Hydroxyeicosapentaenoic acid | HDHA | Hydroxydocosahexaenoic acid |
| EET | Epoxyeicosatrienoic acid | DHET | Dihydroxyeicosatrienoic acid |
| LTB4 | Leukotriene B4 | LXA4 | LipoxinA4 |
| HODE | Hydroxyoctadecadienoic acid | PGE2 | Prostaglandin E2 |
| PGE1 | Prostaglandin E1 | PGD1 | Prostaglandin D1 |
| TXB2 | Thromboxane B2 | DiHDPA | Dihydroxydocosapentaenoic acid |
| SSG | Sagittaria sagittifolia | T2D | Type 2 diabetes |
| PGF2α | Prostaglandin F2α | DiHODE | Dihydroxyoctadecadienoic acid |
| DiHOME | Dihydroxyoctadecenoic acid | MS | Mass spectrometry |
| MRM | Multiple reaction monitoring | LC-MS | Liquid chromatography-mass spectrometry |
| IMS-MS | IM-MS | IMS | Ion mobility-mass spectrometry |
| SFC | Supercritical fluid | DESI-MSI | Desorption electrospray ionisation mass spectrometry imaging |